Back

N-terminal pro-brain natriuretic peptide and resistance to chronic therapy with 75 mg acetylsalicylic acid assessed by point-of-care test - prospective single center study.

2 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Primary care Cardiovascular Disease in Primary Care ESC Premium Access ESC Congress 2019

About the speaker

Photo
Mrs Kamila Marika Cygulska

Bieganski Hospital, Lodz (Poland)

7 More presentations in this session

Presentation thumbnail
Doctor R. Grobben (Utrecht, NL)
Abstract
Presentation thumbnail
Mr K. Saito (Chiba, JP)
Abstract
Presentation thumbnail
Doctor J. Sousa (Funchal, PT)
Abstract Slides
Presentation thumbnail
Presentation thumbnail
Doctor D. Cortez (Sacramento, US)
Abstract

Access the full session

Session thumbnail
Poster Session 5 - Primary care

The Event

Event poster

ESC Congress 2019

2 September 2019 14:00 CET
You may be interested in
thumbnail
Congress Presentation
N-terminal pro-B-type natriuretic peptide concentrations, testing and associations with outcomes: an analysis of the Swedish Heart Failure Registry and the Stockholm CREAtinine Measurements Cohorts
20 May 2023
thumbnail
Congress Presentation
Effects of intravenous lysine acetylsalicylate versus oral aspirin on platelet responsiveness in patients with ST-segment elevation myocardial infarction
27 August 2022
thumbnail
Congress Presentation
Colchicine and af burden reduction in nonpermanent atrial fibrillation
4 April 2025
thumbnail
Congress Presentation
Antithrombotic prescription in secondary cardiovascular prevention: are we following the guidelines?
4 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources